Impel Neuropharma

Developer of an intranasal drug delivery technology for CNS diseases

placeSeattle, Washington, United States calendar_todayFounded 2008 groups158 employees language impelnp.com

Registered entities

Investor mix

9 investors on record; lead investors include KKR, Vivo Capital, 5AM Ventures, VenBio; 1 has since exited.

Investor typeCountShare
Venture capital333%
Private equity333%
Angel & family office111%
Accelerator & incubator111%
Other / undisclosed111%
Coming soon